{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:50:32Z","timestamp":1783090232368,"version":"3.54.6"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.meddos.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T01:45:03Z","timestamp":1667094303000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-7760","authenticated-orcid":false,"given":"Gregory K.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Njeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke C.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"DesRosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-1803","authenticated-orcid":false,"given":"Gordon","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meddos.2022.09.003_bib0001","first-page":"7","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin, 2021"},{"key":"10.1016\/j.meddos.2022.09.003_bib0002","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.meddos.2022.09.003_bib0003","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2007.02.035","article-title":"Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients","volume":"69","author":"Spiotto","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0004","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase iii randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0005","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.eururo.2009.03.012","article-title":"Pelvic lymph node dissection in prostate cancer","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0006","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijrobp.2007.04.003","article-title":"An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone\/radiation interactions","volume":"69","author":"Lawton","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0007","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2016.06.2455","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? update of the long-term survival results of the GETUG-01 randomized study","volume":"96","author":"Pommier","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0008","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1748-717X-6-87","article-title":"The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques","volume":"6","author":"Vranova","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ijrobp.2009.08.043","article-title":"Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer","volume":"78","author":"Deville","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0011","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1200\/JCO.18.02237","article-title":"Treatment-related toxicity using prostate-only versus prostate and pelvic lymph node intensity-modulated radiation therapy: a national population-based study","volume":"37","author":"Parry","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0012","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0013","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ctrv.2010.01.004","article-title":"New developments in arc radiation therapy: a review","volume":"36","author":"Palma","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.meddos.2022.09.003_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jrr\/rru086","article-title":"Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity","volume":"56","author":"Ishii","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.meddos.2022.09.003_bib0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11604-014-0291-3","article-title":"Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer","volume":"32","author":"Onal","year":"2014","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0016","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1120\/jacmp.v17i6.6464","article-title":"Dosimetric comparison of intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy in patients with prostate cancer: a meta-analysis","volume":"17","author":"Ren","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0017","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2008.02.047","article-title":"Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy","volume":"72","author":"Palma","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0018","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.ijrobp.2009.03.033","article-title":"Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases","volume":"76","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0019","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.meddos.2010.09.004","article-title":"VMAT versus 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample","volume":"36","author":"Kopp","year":"2011","journal-title":"Med Dosim"},{"key":"10.1016\/j.meddos.2022.09.003_bib0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2009.07.1677","article-title":"Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes","volume":"76","author":"Yoo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0021","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ijrobp.2010.10.024","article-title":"Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer","volume":"80","author":"Davidson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1259\/bjr\/94843998","article-title":"Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and\/or lymph node involvement","volume":"85","author":"Fontenot","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0023","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/0971-6203.121193","article-title":"Dosimetric comparison between IMRT delivery modes: Step-and-shoot, sliding window, and volumetric modulated arc therapy - for whole pelvis radiation therapy of intermediate-to-high risk prostate adenocarcinoma","volume":"38","author":"Herman Tde","year":"2013","journal-title":"J Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140183","article-title":"A dosimetric analysis of volumetric-modulated arc radiotherapy with jaw width restriction versus 7 field intensity-modulated radiotherapy for definitive treatment of cervical cancer","volume":"87","author":"Huang","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0025","article-title":"A dosimetric study of using fixed-jaw volumetric modulated arc therapy for the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.meddos.2022.09.003_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2020.09.038","article-title":"What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans","volume":"153","author":"Hernandez","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0027","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.09.028","article-title":"Conformity index: a review","volume":"64","author":"Feuvret","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0028","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/jmp.JMP_25_18","article-title":"Evaluation of plan quality metrics in stereotactic radiosurgery\/radiotherapy in the treatment plans of arteriovenous malformations","volume":"43","author":"Menon","year":"2018","journal-title":"J Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0029","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ijrobp.2005.11.005","article-title":"Integral radiation dose to normal structures with conformal external beam radiation","volume":"64","author":"Aoyama","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2008.03.003","article-title":"Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours","volume":"88","author":"Iori","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0031","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2009.08.015","article-title":"Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?","volume":"93","author":"Guckenberger","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0032","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0360-3016(02)02750-5","article-title":"The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets","volume":"53","author":"Pirzkall","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0033","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijrobp.2011.09.015","article-title":"A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment","volume":"83","author":"Quan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/mco.2021.2251","article-title":"VMAT for prostate cancer with 6-MV and 10-MV photons: Impact of beam energy on treatment plan quality and model-based secondary cancer risk estimates","volume":"14","author":"Mazonakis","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1120\/jacmp.v7i4.2263","article-title":"Treatments of exceptionally large prostate cancer patients with low-energy intensity-modulated photons","volume":"7","author":"Sun","year":"2006","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0036","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.meddos.2011.01.005","article-title":"RapidArc radiotherapy planning for prostate cancer: single-arc and double-arc techniques vs. intensity-modulated radiotherapy","volume":"37","author":"Sze","year":"2012","journal-title":"Med Dosim"},{"key":"10.1016\/j.meddos.2022.09.003_bib0037","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ijrobp.2019.11.408","article-title":"Dose gradient index for stereotactic radiosurgery\/radiation therapy","volume":"106","author":"Reynolds","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0038","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1754-9485.13374","article-title":"Plan quality in radiotherapy treatment planning - Review of the factors and challenges","volume":"66","author":"Hansen","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0039","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1088\/0031-9155\/58\/14\/4921","article-title":"Reduction of prostate intrafractional motion from shortening the treatment time","volume":"58","author":"Li","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.rpor.2014.10.010","article-title":"Integral dose: Comparison between four techniques for prostate radiotherapy","volume":"20","author":"Slosarek","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.meddos.2022.09.003_bib0041","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V","article-title":"Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery","volume":"88","author":"Brenner","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.meddos.2022.09.003_bib0042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0043","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmp.2017.02.013","article-title":"Photons - Radiobiological issues related to the risk of second malignancies","volume":"42","author":"Marcu","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.meddos.2022.09.003_bib0044","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acm2.12972","article-title":"Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation","volume":"21","author":"Haciislamoglu","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.meddos.2020.02.001","article-title":"A dosimetric study using split x-jaw planning technique for the treatment of endometrial carcinoma","volume":"45","author":"Keil","year":"2020","journal-title":"Med Dosim"},{"key":"10.1016\/j.meddos.2022.09.003_bib0046","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/acm2.12834","article-title":"The impact of the field width on VMAT plan quality and the assessment of half field method","volume":"21","author":"Ugurlu","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0047","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1120\/jacmp.v17i4.6028","article-title":"A novel arc geometry setting for pelvic radiotherapy with extensive nodal involvement","volume":"17","author":"Rossi","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0048","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1120\/jacmp.v17i1.5808","article-title":"Pinnacle3 modeling and end-to-end dosimetric testing of a Versa HD linear accelerator with the Agility head and flattening filter-free modes","volume":"17","author":"Saenz","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0049","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1748-717X-9-153","article-title":"A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse","volume":"9","author":"Peters","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.meddos.2022.09.003_bib0050","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1120\/jacmp.v15i5.4912","article-title":"The accuracy of Acuros XB algorithm for radiation beams traversing a metallic hip implant - comparison with measurements and Monte Carlo calculations","volume":"15","author":"Ojala","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2022.09.003_bib0051","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.meddos.2020.12.002","article-title":"Why all radiotherapy planning studies are wrong but some are useful","volume":"46","author":"Eaton","year":"2021","journal-title":"Med Dosim"},{"key":"10.1016\/j.meddos.2022.09.003_bib0052","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5732\/cjc.013.10077","article-title":"Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment","volume":"32","author":"Rana","year":"2013","journal-title":"Chin J Cancer"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095839472200070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095839472200070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:32:32Z","timestamp":1760693552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095839472200070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S095839472200070X"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2022.09.003","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of American Association of Medical Dosimetrists.","name":"copyright","label":"Copyright"}]}}